Investment
Features
FeesSafety
Academy
More
Pluang+

Compare International Business Machines Corp (IBM) vs Smith & Nephew plc (SNN) Price & Performance

International Business Machines CorpTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

International Business Machines Corp vs Smith & Nephew plc — how do they compare? International Business Machines Corp trades at $234.31 (market cap $224.62B), while Smith & Nephew plc trades at $29.71 (market cap $12.54B). The key difference: International Business Machines Corp is far larger — about 17.9× Smith & Nephew plc's market cap, and International Business Machines Corp pays the higher dividend (2.84%). Which is the better fit depends on your goals.

IBMSNN
Market Cap
$224.62B$12.54B
Volume
4,481,527
Sector
TechnologyHealth
52-Week High
$329.23$38.70
52-Week Low
$205.77$28.73
Enterprise Value
$281.76B$15.57B
Dividend Yield
2.84%2.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

International Business Machines Corp

IBM trades at $233.94, down 1.0% today, as the stock navigates mixed signals. Recent earnings showed a Q2 2026 EPS miss after two consecutive beats, while revenue growth accelerated to $67.54 billion in 2025. Technical indicators show a bullish overall signal but bearish moving averages, with RSI levels suggesting overbought conditions. The company secured a $240 million AI deal with Together AI, but faces securities fraud investigations following a 25% stock drop earlier this year.

IBM presents a complex risk-reward profile with strong profitability metrics (15.52% net margin, 34.62% ROE) and analyst consensus pointing to 10% upside to the $257.38 price target. However, ongoing legal investigations and increased capital expenditures creating negative cash flow pose significant near-term risks. The AI partnership momentum contrasts with concerns about IBM's competitive positioning in the rapidly evolving technology landscape.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $30.08, down 0.1% with bearish technical signals. The company reported mixed Q2 2026 results with revenue growth below expectations, leading to a reduced full-year outlook. Fundamentals show strong profitability with 10.1% net margin and improving cash flow trends, though recent earnings misses have tempered sentiment.

Outlook remains cautious with analyst consensus at Hold (65% of coverage). Near-term risks include U.S. orthopedics weakness and competitive pressures, offset by robotics innovation and value-based care expansion. The stock offers stable fundamentals but faces execution challenges in key markets.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About International Business Machines Corp

International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.

Read more on IBM

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN